XNAS · Laboratory Analytical Instruments · S&P 500
$4.79
-$0.26 (-5.15%) today
Open $5.05 High $5.15 Low $4.78 Vol 5,355K Avg $4.89
Find similar stocks by technical condition — S&P 500 universe
| Symbol | Company Name | Exchange | Currency | Category |
|---|---|---|---|---|
| NABL | N-able, Inc. | XNYS | USD | SERVICES-PREPACKAGED SOFTWARE |
| EXFY | Expensify, Inc. Class A Common Stock | XNAS | USD | SERVICES-PREPACKAGED SOFTWARE |
| CERT | Certara, Inc. Common Stock | XNAS | USD | SERVICES-PREPACKAGED SOFTWARE |
| SNPS | Synopsys Inc | XNAS | USD | SERVICES-PREPACKAGED SOFTWARE |
| AMPL | Amplitude, Inc. Class A Common Stock | XNAS | USD | SERVICES-PREPACKAGED SOFTWARE |
| BNZI | Banzai International, Inc. Class A Common Stock | XNAS | USD | SERVICES-PREPACKAGED SOFTWARE |
| NOW | SERVICENOW, INC. | XNYS | USD | SERVICES-PREPACKAGED SOFTWARE |
| CDNS | Cadence Design Systems | XNAS | USD | SERVICES-PREPACKAGED SOFTWARE |
| FIG | Figma, Inc. | XNYS | USD | SERVICES-PREPACKAGED SOFTWARE |
| MRDN | Meridian Holdings Inc. Common Stock | XNAS | USD | SERVICES-PREPACKAGED SOFTWARE |
52-week price range
Price is 0.0% above its 52-week low and 0.0% below its 52-week high. Trading in the lower half of its annual range — closer to the floor than the ceiling.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.